Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Revenue 2010-2024 | MKKGY

Merck annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Merck revenue for the quarter ending June 30, 2024 was $5.764B, a 0.31% decline year-over-year.
  • Merck revenue for the twelve months ending June 30, 2024 was $22.580B, a 2.37% decline year-over-year.
  • Merck annual revenue for 2023 was $22.721B, a 3% decline from 2022.
  • Merck annual revenue for 2022 was $23.424B, a 0.57% increase from 2021.
  • Merck annual revenue for 2021 was $23.292B, a 16.29% increase from 2020.
  
Merck Annual Revenue
(Millions of US $)
2023 $22,721
2022 $23,424
2021 $23,292
2020 $20,029
2019 $18,090
2018 $17,521
2017 $17,324
2016 $16,626
2015 $14,254
2014 $15,288
2013 $14,738
2012 $14,369
2011 $13,799
2010 $12,338
2009 $10,807
Merck Quarterly Revenue
(Millions of US $)
2024-06-30 $5,764
2024-03-31 $5,559
2023-12-31 $5,628
2023-09-30 $5,630
2023-06-30 $5,781
2023-03-31 $5,682
2022-12-31 $5,817
2022-09-30 $5,848
2022-06-30 $5,925
2022-03-31 $5,833
2021-12-31 $5,977
2021-09-30 $5,864
2021-06-30 $5,868
2021-03-31 $5,583
2020-12-31 $5,474
2020-09-30 $5,199
2020-06-30 $4,535
2020-03-31 $4,821
2019-12-31 $4,864
2019-09-30 $4,508
2019-06-30 $4,464
2019-03-31 $4,255
2018-12-31 $4,196
2018-09-30 $4,359
2018-06-30 $4,429
2018-03-31 $4,537
2017-12-31 $4,549
2017-09-30 $4,380
2017-06-30 $4,280
2017-03-31 $4,115
2016-12-31 $4,128
2016-09-30 $4,156
2016-06-30 $4,298
2016-03-31 $4,043
2015-12-31 $3,795
2015-09-30 $3,489
2015-06-30 $3,560
2015-03-31 $3,464
2014-12-31 $3,398
2014-09-30 $3,896
2014-06-30 $3,827
2014-03-31 $3,654
2013-12-31 $3,729
2013-09-30 $3,645
2013-06-30 $3,769
2013-03-31 $3,581
2012-12-31 $3,646
2012-09-30 $3,555
2012-06-30 $3,520
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
2011-06-30 $3,677
2011-03-31 $3,505
2010-12-31 $3,707
2010-09-30 $3,145
2010-06-30 $2,695
2010-03-31 $2,791
2009-12-31 $2,983
2009-09-30 $2,778
2009-06-30 $2,590
2009-03-31 $2,456
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $19.076B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.098B 30.44
Takeda Pharmaceutical (TAK) Japan $43.496B 9.05
Astellas Pharma (ALPMY) Japan $19.237B 17.72
Sandoz Group AG (SDZNY) Switzerland $18.813B 0.00
United Therapeutics (UTHR) United States $16.715B 16.44
Summit Therapeutics (SMMT) United States $12.979B 0.00
Neurocrine Biosciences (NBIX) United States $12.933B 34.25
Shionogi (SGIOY) Japan $12.199B 12.22
Catalent (CTLT) United States $11.225B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.946B 0.00
Orion OYJ (ORINY) Finland $6.605B 18.57
Corcept Therapeutics (CORT) United States $6.376B 48.29
Ionis Pharmaceuticals (IONS) United States $5.866B 0.00
Crinetics Pharmaceuticals (CRNX) United States $5.296B 0.00
PTC Therapeutics (PTCT) United States $3.845B 0.00
Dyne Therapeutics (DYN) United States $2.996B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.730B 16.32
Catalyst Pharmaceuticals (CPRX) United States $2.619B 11.87
Centessa Pharmaceuticals (CNTA) United Kingdom $2.262B 0.00
Soleno Therapeutics (SLNO) United States $2.185B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.044B 0.00
Xencor (XNCR) United States $1.834B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.688B 0.00
Evotec AG (EVO) Germany $1.623B 0.00
Guardian Pharmacy Services (GRDN) United States $1.568B 0.00
Indivior (INDV) United States $1.566B 6.38
BioCryst Pharmaceuticals (BCRX) United States $1.518B 0.00
Ocular Therapeutix (OCUL) United States $1.490B 0.00
ARS Pharmaceuticals (SPRY) United States $1.401B 0.00
Harrow (HROW) United States $1.356B 0.00
Ardelyx (ARDX) United States $1.322B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.249B 0.00
Enliven Therapeutics (ELVN) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.004B 5.48
Avadel Pharmaceuticals (AVDL) Ireland $0.960B 0.00
Bioventus (BVS) United States $0.896B 28.31
Cronos Group (CRON) Canada $0.772B 0.00
USANA Health Sciences (USNA) United States $0.736B 13.64
Relay Therapeutics (RLAY) United States $0.735B 0.00
Oruka Therapeutics (ORKA) United States $0.734B 0.00
Esperion Therapeutics (ESPR) United States $0.721B 0.00
Altimmune (ALT) United States $0.701B 0.00
Tourmaline Bio (TRML) United States $0.656B 0.00
Elite Pharmaceuticals (ELTP) United States $0.635B 0.00
Savara (SVRA) United States $0.589B 0.00
ProKidney (PROK) United States $0.586B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.568B 0.00
Verve Therapeutics (VERV) United States $0.561B 0.00
OmniAb (OABI) United States $0.541B 0.00
Xeris Biopharma Holdings (XERS) United States $0.532B 0.00
Organogenesis (ORGO) United States $0.505B 0.00
Zevra Therapeutics (ZVRA) United States $0.490B 0.00
Siga Technologies (SIGA) United States $0.478B 5.58
Theravance Biopharma (TBPH) Cayman Islands $0.472B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.467B 189.21
Akebia Therapeutics (AKBA) United States $0.443B 0.00
KalVista Pharmaceuticals (KALV) United States $0.409B 0.00
Aquestive Therapeutics (AQST) United States $0.393B 0.00
Larimar Therapeutics (LRMR) United States $0.388B 0.00
Korro Bio (KRRO) United States $0.362B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.361B 0.00
Sage Therapeutics (SAGE) United States $0.343B 0.00
Avita Medical (RCEL) United States $0.337B 0.00
4D Molecular Therapeutics (FDMT) United States $0.330B 0.00
Nature's Sunshine Products (NATR) United States $0.297B 17.67
Aldeyra Therapeutics (ALDX) United States $0.295B 0.00
Lyell Immunopharma (LYEL) United States $0.275B 0.00
Aclaris Therapeutics (ACRS) United States $0.269B 0.00
Heron Therapeutics (HRTX) United States $0.249B 0.00
Silence Therapeutics (SLN) United Kingdom $0.248B 0.00
Lexeo Therapeutics (LXEO) United States $0.223B 0.00
Acrivon Therapeutics (ACRV) United States $0.210B 0.00
Profound Medical (PROF) Canada $0.203B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.195B 0.00
MediWound (MDWD) Israel $0.194B 0.00
Nektar Therapeutics (NKTR) United States $0.188B 0.00
Inhibikase Therapeutics (IKT) United States $0.184B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.181B 0.00
Achieve Life Sciences (ACHV) Canada $0.156B 0.00
Telomir Pharmaceuticals (TELO) United States $0.153B 0.00
Galectin Therapeutics (GALT) United States $0.148B 0.00
Cassava Sciences (SAVA) United States $0.142B 0.00
Nanobiotix S.A (NBTX) France $0.136B 0.00
CytoDyn (CYDY) United States $0.134B 0.00
VAXART, INC (VXRT) United States $0.130B 0.00
Century Therapeutics (IPSC) United States $0.122B 0.00
Cardiol Therapeutics (CRDL) Canada $0.121B 0.00
Journey Medical (DERM) United States $0.117B 0.00
Context Therapeutics (CNTX) United States $0.113B 0.00
Pyxis Oncology (PYXS) United States $0.107B 0.00
Regulus Therapeutics (RGLS) United States $0.105B 0.00
Fractyl Health (GUTS) United States $0.105B 0.00
Avalo Therapeutics (AVTX) United States $0.104B 0.00
Innate Pharma SA (IPHYF) France $0.103B 0.00
Inotiv (NOTV) United States $0.102B 0.00
Karyopharm Therapeutics (KPTI) United States $0.100B 0.00
Assertio Holdings (ASRT) United States $0.092B 24.05
Arch Biopartners (ACHFF) Canada $0.090B 0.00
PMV Pharmaceuticals (PMVP) United States $0.087B 0.00
Vivani Medical (VANI) United States $0.079B 0.00
OptiNose (OPTN) United States $0.078B 0.00
Swiftmerge Acquisition (IVCP) United States $0.077B 0.00
ElectroCore (ECOR) United States $0.075B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Unicycive Therapeutics (UNCY) United States $0.074B 0.00
Protara Therapeutics (TARA) United States $0.073B 0.00
Metagenomi (MGX) United States $0.070B 0.00
Mural Oncology (MURA) Ireland $0.068B 0.00
Iterum Therapeutics (ITRM) Ireland $0.066B 0.00
Scienture Holdings (SCNX) United States $0.064B 0.00
AlloVir (ALVR) United States $0.061B 0.00
Champions Oncology (CSBR) United States $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
CASI Pharmaceuticals (CASI) China $0.053B 0.00
Prelude Therapeutics (PRLD) United States $0.052B 0.00
BioVie (BIVI) United States $0.049B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Nutriband (NTRB) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.048B 0.00
Rafael Holdings (RFL) United States $0.045B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.042B 0.00
FibroGen (FGEN) United States $0.041B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
Tempest Therapeutics (TPST) United States $0.038B 0.00
Surrozen (SRZN) United States $0.036B 0.00
Carisma Therapeutics (CARM) United States $0.034B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.033B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.031B 0.00
Incannex Healthcare (IXHL) Australia $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Natural Alternatives (NAII) United States $0.028B 0.00
Citius Pharmaceuticals (CTXR) United States $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
CERo Therapeutics Holdings (CERO) United States $0.026B 0.00
DURECT (DRRX) United States $0.026B 0.00
BioLineRx (BLRX) Israel $0.022B 0.00
Mannatech (MTEX) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
GlycoMimetics (GLYC) United States $0.019B 0.00
Relmada Therapeutics (RLMD) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.017B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.015B 0.00
NRx Pharmaceuticals (NRXP) United States $0.015B 0.00
PolyPid (PYPD) Israel $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
Talphera (TLPH) United States $0.012B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Conduit Pharmaceuticals (CDT) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
Redhill Biopharma (RDHL) Israel $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
Aditxt (ADTX) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.10
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Molecular Templates (MTEM) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.04
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 39.43